Literature DB >> 8831112

Lamotrigine inhibits Ca2+ currents in cortical neurons: functional implications.

A Stefani1, F Spadoni, A Siniscalchi, G Bernardi.   

Abstract

In pyramidal cortical cells, high-voltage-activated Ca2+ currents affect seizure propagation and the release of excitatory amino acids at the corticostriatal axon terminals. The new antiepileptic drug lamotrigine (Lamictal) produced a large and dose-dependent inhibition of high-voltage-activated Ca2+ currents (IC50 = 12.3 microM) in rat cortical neurons. This action was not blocked by the dihydropyridine receptor antagonist nifedipine; instead, the response was blocked by the concomitant application of the N-type Ca2+ channel blocker, omega-conotoxin GVIA (1-3 microM) and the P-type Ca2+ channel blocker, omega-agatoxin-IVA (20-100 nM). These findings demonstrate that lamotrigine, at therapeutic doses, is capable of modulating the Ca2+ conductances involved in excitatory amino acid release in the corticostriatal pathway, partially explaining lamotrigine usefulness in the therapy of epilepsy as well as in the treatment of excitatory amino acid-induced neurotoxicity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8831112     DOI: 10.1016/0014-2999(96)00265-8

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  32 in total

Review 1.  NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development.

Authors:  John H Krystal; D Cyril D'Souza; Daniel Mathalon; Edward Perry; Aysenil Belger; Ralph Hoffman
Journal:  Psychopharmacology (Berl)       Date:  2003-09-02       Impact factor: 4.530

Review 2.  P/Q-type calcium channel modulators.

Authors:  V Nimmrich; G Gross
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

Review 3.  Molecular targets versus models for new antiepileptic drug discovery.

Authors:  Michael A Rogawski
Journal:  Epilepsy Res       Date:  2006-01       Impact factor: 3.045

Review 4.  Central mechanism of action of antimigraine prophylactic drugs.

Authors:  Gerardo Casucci; Veronica Villani; Fabio Frediani
Journal:  Neurol Sci       Date:  2008-05       Impact factor: 3.307

5.  Mechanisms of deafferentation-induced plasticity in human motor cortex.

Authors:  U Ziemann; M Hallett; L G Cohen
Journal:  J Neurosci       Date:  1998-09-01       Impact factor: 6.167

6.  Levetiracetam inhibits glutamate transmission through presynaptic P/Q-type calcium channels on the granule cells of the dentate gyrus.

Authors:  Chun-Yao Lee; Chih-Chuan Chen; Horng-Huei Liou
Journal:  Br J Pharmacol       Date:  2009-12       Impact factor: 8.739

7.  Lidocaine and carbamazepine inhibit while phenytoin and lamotrigine paradoxically enhance the insect neuromuscular transmission.

Authors:  Irina M Fedorova; Denis B Tikhonov
Journal:  Invert Neurosci       Date:  2019-02-08

8.  Pharmacogenomics of mood stabilizers in the treatment of bipolar disorder.

Authors:  Alessio Squassina; Mirko Manchia; Maria Del Zompo
Journal:  Hum Genomics Proteomics       Date:  2010-08-03

9.  Is aspirin useful in patients on lithium? A pharmacoepidemiological study related to bipolar disorder.

Authors:  Pieter Stolk; Patrick C Souverein; Ingeborg Wilting; Hubert G M Leufkens; Donald F Klein; Stanley I Rapoport; Eibert R Heerdink
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2009-11-25       Impact factor: 4.006

10.  Spotlight on lamotrigine in bipolar disorder.

Authors:  David R Goldsmith; Antona J Wagstaff; Tim Ibbotson; Caroline M Perry
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.